329 related articles for article (PubMed ID: 29342159)
21. Integrated analysis of RNA-binding proteins in human colorectal cancer.
Fan X; Liu L; Shi Y; Guo F; Wang H; Zhao X; Zhong D; Li G
World J Surg Oncol; 2020 Aug; 18(1):222. PubMed ID: 32828126
[TBL] [Abstract][Full Text] [Related]
22. Identification of key pathways and genes in Barrett's esophagus using integrated bioinformatics methods.
Zhang C; Shen Y; Wang J; Zhou M; Chen Y
Mol Med Rep; 2018 Feb; 17(2):3069-3077. PubMed ID: 29257318
[TBL] [Abstract][Full Text] [Related]
23. Investigation of differentially-expressed microRNAs and genes in cervical cancer using an integrated bioinformatics analysis.
Xu Z; Zhou Y; Shi F; Cao Y; Dinh TLA; Wan J; Zhao M
Oncol Lett; 2017 Apr; 13(4):2784-2790. PubMed ID: 28454467
[TBL] [Abstract][Full Text] [Related]
24. Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer.
Yu C; Xue P; Zhang L; Pan R; Cai Z; He Z; Sun J; Zheng M
World J Surg Oncol; 2018 Aug; 16(1):174. PubMed ID: 30134903
[TBL] [Abstract][Full Text] [Related]
25. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
26. Construction of an immunorelated protein-protein interaction network for clarifying the mechanism of burn.
Gao Y; Nai W; Yang L; Lu Z; Shi P; Jin H; Wen H; Wang G
Burns; 2016 Mar; 42(2):405-13. PubMed ID: 26739088
[TBL] [Abstract][Full Text] [Related]
27. Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer.
Yu C; Hong H; Lu J; Zhao X; Hu W; Zhang S; Zong Y; Mao Z; Li J; Wang M; Feng B; Sun J; Zheng M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806905. PubMed ID: 30336768
[TBL] [Abstract][Full Text] [Related]
28. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
Liang B; Li C; Zhao J
Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
[TBL] [Abstract][Full Text] [Related]
29. Screening the molecular targets of ovarian cancer based on bioinformatics analysis.
Du L; Qian X; Dai C; Wang L; Huang D; Wang S; Shen X
Tumori; 2015; 101(4):384-9. PubMed ID: 25953442
[TBL] [Abstract][Full Text] [Related]
30. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis.
Feng H; Gu ZY; Li Q; Liu QH; Yang XY; Zhang JJ
J Ovarian Res; 2019 Apr; 12(1):35. PubMed ID: 31010415
[TBL] [Abstract][Full Text] [Related]
31. Involvement of enhancer of zeste homolog 2 in cisplatin-resistance in ovarian cancer cells by interacting with several genes.
Wang H; Yu Y; Chen C; Wang Q; Huang T; Hong F; Zhu L
Mol Med Rep; 2015 Aug; 12(2):2503-10. PubMed ID: 25955318
[TBL] [Abstract][Full Text] [Related]
32. Identification of key candidate genes, pathways and related prognostic values in ER-negative/HER2-negative breast cancer by bioinformatics analysis.
Shao N; Yuan K; Zhang Y; Yun Cheang T; Li J; Lin Y
J BUON; 2018; 23(4):891-901. PubMed ID: 30358191
[TBL] [Abstract][Full Text] [Related]
33. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
Fang E; Zhang X
Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
[TBL] [Abstract][Full Text] [Related]
34. Identification of key genes and crucial modules associated with coronary artery disease by bioinformatics analysis.
Zhang X; Cheng X; Liu H; Zheng C; Rao K; Fang Y; Zhou H; Xiong S
Int J Mol Med; 2014 Sep; 34(3):863-9. PubMed ID: 24969630
[TBL] [Abstract][Full Text] [Related]
35. Screening of the prognostic targets for breast cancer based co-expression modules analysis.
Liu H; Ye H
Mol Med Rep; 2017 Oct; 16(4):4038-4044. PubMed ID: 28731166
[TBL] [Abstract][Full Text] [Related]
36. Identification of key pathways and biomarkers in sorafenib-resistant hepatocellular carcinoma using bioinformatics analysis.
Huang D; Yuan W; Li H; Li S; Chen Z; Yang H
Exp Ther Med; 2018 Sep; 16(3):1850-1858. PubMed ID: 30186410
[TBL] [Abstract][Full Text] [Related]
37. Bioinformatics analysis of gene expression profile data to screen key genes involved in pulmonary sarcoidosis.
Li H; Zhao X; Wang J; Zong M; Yang H
Gene; 2017 Jan; 596():98-104. PubMed ID: 27682024
[TBL] [Abstract][Full Text] [Related]
38. A comprehensive analysis of candidate genes and pathways in pancreatic cancer.
Liu J; Li J; Li H; Li A; Liu B; Han L
Tumour Biol; 2015 Mar; 36(3):1849-57. PubMed ID: 25409614
[TBL] [Abstract][Full Text] [Related]
39. Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer.
Zuurbier L; Rahman A; Cordes M; Scheick J; Wong TJ; Rustenburg F; Joseph JC; Dynoodt P; Casey R; Drillenburg P; Gerhards M; Barat A; Klinger R; Fender B; O'Connor DP; Betge J; Ebert MP; Gaiser T; Prehn JHM; Griffioen AW; van Grieken NCT; Ylstra B; Byrne AT; van der Flier LG; Gallagher WM; Postel R
Oncotarget; 2017 Jun; 8(26):42949-42961. PubMed ID: 28487489
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling analysis contributes to understanding the association between non-syndromic cleft lip and palate, and cancer.
Wang H; Qiu T; Shi J; Liang J; Wang Y; Quan L; Zhang Y; Zhang Q; Tao K
Mol Med Rep; 2016 Mar; 13(3):2110-6. PubMed ID: 26795696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
